RXO Dedicated Transportation Named 2024 SmartWay High Performer

CHARLOTTE, N.C.--(BUSINESS WIRE)-- RXO (NYSE: RXO), a leading provider of asset-light transportation solutions, announced its dedicated transportation business was recognized as a 2024 SmartWay High Performer by the U.S. Environmental Protection Agency (EPA) in the Truckload / Dry Van Truck Carrier Carbon Metrics category.

EPA’s SmartWay program is dedicated to enhancing the efficiency and sustainability of supply chain transportation. RXO was recognized for the second straight year for achieving efficiency and/or air quality performance within the top-ranked performance range.

“It is an honor to be recognized again by the EPA as a SmartWay High Performer,” said Brian Dean, president of RXO’s managed transportation business. “Our dedication to customer service and supply chain sustainability is steadfast, and SmartWay’s tools for measuring, benchmarking and enhancing transportation efficiency are crucial to our efforts.”

SmartWay reports that fewer than 10 percent of all participating carriers achieve the efficiency levels required to be recognized for reduced carbon emissions. Carbon emissions correlate with fuel consumption, and SmartWay High Performers use less fuel per mile and per ton of freight transported.

For more information on RXO, visit https://rxo.com.

About RXO

RXO (NYSE: RXO) is a leading provider of asset-light transportation solutions. RXO offers tech-enabled truck brokerage services together with complementary solutions including managed transportation and last mile delivery. The company combines massive capacity and cutting-edge technology to move freight efficiently through supply chains across North America. The company is headquartered in Charlotte, N.C. Visit RXO.com for more information and connect with RXO on Facebook, X, LinkedIn, Instagram and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240815521327/en/

Media
Erin Kelly
[email protected]

Source: RXO

You May Also Be Interested In

• New ASIS International Research Sponsored by Everbridge Finds Critical Gaps in Active Assailant Preparedness
• UDC Korea Honored with Forbes 2026 Korea Trusted Innovation Award
• Sarepta Therapeutics Presents New Data at 2026 World Muscle Society Annual Congress Demonstrating Safety and Clinically Meaningful Functional Benefit of ELEVIDYS (delandistrogene moxeparvovec) in Olde